Not checkedNot checked for notices yet.
Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia
Melaku Tadege
BMC Research Notes · 2018
doi:10.1186/s13104-018-3863-y (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Abstract Objective The purpose of this study was to identify the major risk factors, which contributed to shortened survival time to death of HIV patients on antiretroviral therapy. Six-hundred HIV patients were included from two hospitals and six health centers record from January 2003 to December 2017. Kaplan–Meier and Cox proportional hazard model were implemented. Results From the Kaplan–Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P =.000), occupation (P =.027), and WHO clinical stage (P =.012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.